American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US
Lead: Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US
Lead: Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US
Tuesday 12th September 2023
Explore cannabis use disorder prevalence, endocannabinoid signaling, and more in ASAM's 'Addiction Medicine Unpacked' podcast.
9 minutes
Informative
Empowering
Inspiring
Hopeful
Educational
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
169 (View all)
Do you want to link to this podcast?
Get the buttons here!Cannabis Use Disorder and Beyond: Insights from ASAM
Episode Overview
- Exploration of cannabis use disorder prevalence and reasons for use among adults in the US
- Insight into endocannabinoid signaling mechanisms and their impact on stress-induced plasticity
- Study on the validity of diagnostic assessments for opioid and stimulant use disorder by non-clinicians
- Analysis of fentanyl concentration in drug checking samples and its correlation with overdose deaths
- Discussion on racial inequities in addiction research and efforts to address disparities among researchers
Screening for CUD among patients who use cannabis is paramount. The endocannabinoid system negatively regulates alcohol consumption and boosting selective ECBs exogenously has beneficial effects against alcohol consumption and potentially in preventing relapse.
Ever wondered about the complexities of cannabis use disorder, especially in states where recreational use is legal? This episode of 'Addiction Medicine Unpacked' by the American Society of Addiction Medicine dives into a fascinating study on the prevalence of cannabis use disorder (CUD) among primary care patients. The findings reveal that 21.3% of users experience some form of CUD, with 6.5% facing moderate to severe issues.
What's more, the reasons for cannabis use vary significantly, with some using it for medical purposes, others for nonmedical reasons, and a notable portion for both. This nuanced look at cannabis use is just the tip of the iceberg. The episode also delves into the nitty-gritty of endocannabinoid signaling and its impact on stress-induced plasticity. You’ll hear about diagnostic assessments for opioid and stimulant use disorders, and the alarming concentrations of fentanyl found in drug samples linked to overdose deaths.
The discussion doesn’t stop there; it covers racial inequities in addiction research and how epigenetic changes are tied to opioid overdoses. Ever wondered how long-term use of buprenorphine affects cognitive performance? This episode has you covered. Finally, the role of the endocannabinoid system in alcohol addiction is explored, giving you a comprehensive look at the many facets of addiction medicine.
Perfect for healthcare professionals, students, or anyone touched by addiction, this episode offers a blend of research findings and practical insights.